Close
Smartlab Europe
Achema middle east

News

Brazil approves Sinovac and Astrazeneca Covid-19 vaccines for emergency use

Brazil has granted approval to AstraZeneca and Chinese firm Sinovac Biotech’c Covid-19 vaccines for emergency use, allowing the country to begin inoculation as cases surge. Brazilian health regulator Anvisa approved the vaccines citing a rise in cases, as well as...

DARZALEX FASPRO Becomes the First FDA-Approved Treatment for Patients with Newly Diagnosed Light Chain (AL) Amyloidosis

The Janssen Pharmaceutical Companies of Johnson & Johnson announced today the U.S. FDA approval of DARZALEX FASPRO® (daratumumab and hyaluronidase-fihj), a subcutaneous formulation of daratumumab, in combination with bortezomib, cyclophosphamide and dexamethasone (D-VCd) for the treatment of adult patients...

Thermo Fisher Scientific Acquires Viral Vector Manufacturing Business from Novasep

Thermo Fisher Scientific Inc., the world leader in serving science, and Groupe Novasep SAS (Novasep), a leading supplier of services and technologies for the life sciences industry, announced that Thermo Fisher has completed the acquisition of Henogen S.A., Novasep's...

Dr. Reddy’s receives approval to conduct Phase 3 clinical trial for Sputnik V vaccine in India

Dr. Reddy’s Laboratories Ltd announced that it has received approval from the Drugs Control General of India (DCGI) to conduct phase 3 clinical trial for the Sputnik V vaccine in India. The phase 3 study of Sputnik V will be...

COVID-19 vaccine: Bharat Biotech set to dispatch first consignment of Covaxin

Hyderabad, Bharat Biotech, which has received Emergency Use Authorisation approval from theDrug Controller General of Indiafor its COVID-19 vaccine Covaxin, is set to dispatch it from the Rajv Gandhi International Airport here on Tuesday evening, a senior official of...

Parexel Completes Separation of Parexel Informatics and Medical Imaging Business

Parexel, a leading provider of solutions to accelerate the development and delivery of innovative therapies to improve world health, from clinical through commercialization, announced it has completed the separation of its Parexel Informatics and Medical Imaging business. The strategic...

Lonza to Partner with Capricor Therapeutics for the Development of Duchenne Muscular Dystrophy Cell Therapy

Lonza and Capricor Therapeutics, a US-based clinical-stage biotechnology company, announced on Jan. 12, 2020 that they are entering into an agreement for the development of CAP-1002, Capricor's clinical cell therapy that uses allogeneic cardiosphere-derived cells technology for the treatment...

Subscribe

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from any location or device.

Must read

Translate »